| Associate Director, M&A Planning & Integration |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Oct 17, 2024 |
| Assistant Manager - FC&C |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
Oct 17, 2024 |
| Record to Report (R2R) Specialist |
New Cairo |
Egypt |
Finance |
CTS |
Audit & Finance |
Oct 18, 2024 |
| Record to Report (R2R) Section Head |
New Cairo |
Egypt |
Finance |
CTS |
Audit & Finance |
Oct 18, 2024 |
| Global FC&C Process Expert (Senior Manager) PIN-PCA |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
Oct 03, 2024 |
| P2P Service Delivery (SD) Lead NGSC |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 07, 2024 |
| Finance Control and Compliance US Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 08, 2024 |
| General Accounting Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 09, 2024 |
| Procure to Pay Business Partner Management |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 16, 2024 |
| Order to Cash RLT Sr. Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 16, 2024 |
| Alternant CONTRÔLE DE GESTION - BPA |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Finance |
Innovative Medicines |
Others |
May 17, 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Jun 26, 2024 |
| Manager, Financial Control & Compliance (FC&C) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Oct 06, 2024 |
| Treasury Manager |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Jun 20, 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Jul 25, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Jul 17, 2024 |
| Territory Business Executive |
Madhya Pradesh |
India |
International |
Innovative Medicines |
Sales |
Oct 03, 2024 |
| Territory Business Executive |
Telangana |
India |
International |
Innovative Medicines |
Sales |
Oct 04, 2024 |
| Territory Business Executive |
Kerala |
India |
International |
Innovative Medicines |
Sales |
Oct 04, 2024 |
| Job Posting Title Sales Representative (w/m/d), TA: Onkologie, Gebiet: Österreich West |
Vienna |
Austria |
International |
Innovative Medicines |
Sales |
Oct 07, 2024 |
| Medical Science Liaison (MSL), Czech Republic |
Prague |
Czech Republic |
International |
Innovative Medicines |
Research & Development |
Sep 27, 2024 |
| Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) |
Field Force (Scotland) |
United Kingdom |
International |
Innovative Medicines |
Sales |
Sep 27, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Sep 29, 2024 |
| Medical Science Liaison, Immunology |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Research & Development |
Sep 30, 2024 |
| Senior Market Access Manager |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Market Access |
Sep 30, 2024 |
| Territory Business Executive |
Orissa |
India |
International |
Innovative Medicines |
Sales |
Sep 30, 2024 |
| Regional Business Manager |
Bangalore (Office) |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Zonal Business Manager |
Delhi (Office) |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Zonal Business Manager |
Mumbai (Head Office) |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Assam |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Orissa |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Gujarat |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Maharashtra |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| Territory Business Executive |
Telangana |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| Maintenance Coordinator (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Technical Operations |
Oct 09, 2024 |
| Customer Activation Manager |
Warsaw |
Poland |
International |
Innovative Medicines |
Data and Digital |
Oct 09, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| RWE Lead |
Sintra |
Portugal |
International |
Innovative Medicines |
Market Access |
Oct 10, 2024 |
| Territory Business Executive |
Uttar Pradesh |
India |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |